Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Working Capital/Sales

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 2.152.313.244.014.89

What is the latest Working Capital/Sales ratio of VENUS REMEDIES ?

The latest Working Capital/Sales ratio of VENUS REMEDIES is 2.15 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20242.15
Mar20232.31
Mar20223.24
Mar20214.01
Mar20204.89

How is Working Capital/Sales of VENUS REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2024 2.15
-6.93
Mar2023 2.31
-28.70
Mar2022 3.24
-19.20
Mar2021 4.01
-18.00
Mar2020 4.89 -

Other Financial Ratios of VENUS REMEDIES


Compare Working Capital/Sales ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹408.0 Cr -5.3% 1.1% -16.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,259.0 Cr 0.5% -3.4% 13.4% Stock Analytics
DIVIS LABORATORIES ₹154,917.0 Cr -2.2% 0.3% 58.8% Stock Analytics
CIPLA ₹119,705.0 Cr 2.2% 3.9% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,953.9 Cr -1.5% -7% -5% Stock Analytics
ZYDUS LIFESCIENCES ₹91,889.3 Cr -2.3% -7.4% 3.7% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-5.3%

1.1%

-16.2%

SENSEX

-0.4%

-1.4%

5.4%


You may also like the below Video Courses